IL FENOMENO DI LANDOLT IN TRE CASI DI EPILESSIA FARMACORESISTENTE TRATTATI CON VIGABATRIN

M. Gianelli; R. Cantello; D. Bettucci; P. Naldi; C. Civardi; E. Terazzi; D. Cella; M. P. Schiavella; R. Mutani

IL FENOMENO DI LANDOLT IN TRE CASI DI EPILESSIA FARMACORESISTENTE TRATTATI CON VIGABATRIN

M. Gianelli
, R. Cantello
, D. Bettucci
, P. Naldi
, C. Civardi
, E. Terazzi
, D. Cella
, M. P. Schiavella
, R. Mutani

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Three women suffered from partial cryptogenetic epilepsy resistant to treatment with PB + CBZ. They had no clear history of psychosis. After 1-12 months of GVG treatment as add-on drug (2-4 g daily), they showed a clear improvement in their seizure frequency. However, they developed a psychotic picture which required neuroleptic administration and GVG withdrawal. We think these cases resemble those of 'forced normalization' described by Landolt. A common factor were low levels of plasma folic acid.

Titolo tradotto del contributo	Landolt's phenomenon in three cases of refractory epilepsy treated with Vigabatrin
Lingua originale	Italian
pagine (da-a)	163-166
Numero di pagine	4
Rivista	Bollettino - Lega Italiana contro l'Epilessia
Numero di pubblicazione	84
Stato di pubblicazione	Pubblicato - 1993
Pubblicato esternamente	Sì

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{769837cdb0f24ed3b408999ba47200a7,

title = "IL FENOMENO DI LANDOLT IN TRE CASI DI EPILESSIA FARMACORESISTENTE TRATTATI CON VIGABATRIN",

abstract = "Three women suffered from partial cryptogenetic epilepsy resistant to treatment with PB + CBZ. They had no clear history of psychosis. After 1-12 months of GVG treatment as add-on drug (2-4 g daily), they showed a clear improvement in their seizure frequency. However, they developed a psychotic picture which required neuroleptic administration and GVG withdrawal. We think these cases resemble those of 'forced normalization' described by Landolt. A common factor were low levels of plasma folic acid.",

author = "M. Gianelli and R. Cantello and D. Bettucci and P. Naldi and C. Civardi and E. Terazzi and D. Cella and Schiavella, \{M. P.\} and R. Mutani",

year = "1993",

language = "Italian",

pages = "163--166",

journal = "Bollettino - Lega Italiana contro l'Epilessia",

issn = "0394-560X",

publisher = "Lega Italiana contro l'Epilessia",

number = "84",

}

TY - JOUR

T1 - IL FENOMENO DI LANDOLT IN TRE CASI DI EPILESSIA FARMACORESISTENTE TRATTATI CON VIGABATRIN

AU - Gianelli, M.

AU - Cantello, R.

AU - Bettucci, D.

AU - Naldi, P.

AU - Civardi, C.

AU - Terazzi, E.

AU - Cella, D.

AU - Schiavella, M. P.

AU - Mutani, R.

PY - 1993

Y1 - 1993

N2 - Three women suffered from partial cryptogenetic epilepsy resistant to treatment with PB + CBZ. They had no clear history of psychosis. After 1-12 months of GVG treatment as add-on drug (2-4 g daily), they showed a clear improvement in their seizure frequency. However, they developed a psychotic picture which required neuroleptic administration and GVG withdrawal. We think these cases resemble those of 'forced normalization' described by Landolt. A common factor were low levels of plasma folic acid.

AB - Three women suffered from partial cryptogenetic epilepsy resistant to treatment with PB + CBZ. They had no clear history of psychosis. After 1-12 months of GVG treatment as add-on drug (2-4 g daily), they showed a clear improvement in their seizure frequency. However, they developed a psychotic picture which required neuroleptic administration and GVG withdrawal. We think these cases resemble those of 'forced normalization' described by Landolt. A common factor were low levels of plasma folic acid.

UR - https://www.scopus.com/pages/publications/0027818567

M3 - Articolo in rivista

AN - SCOPUS:0027818567

SN - 0394-560X

SP - 163

EP - 166

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

IS - 84

ER -

IL FENOMENO DI LANDOLT IN TRE CASI DI EPILESSIA FARMACORESISTENTE TRATTATI CON VIGABATRIN

Abstract

Altri file e collegamenti

Fingerprint

Cita questo